Telomerase RNA component, also known as TERC, is an ncRNA found in eukaryotes that is a component of telomerase, the enzyme used to extend telomeres.[1][2] TERC serves as a template for telomere replication (reverse transcription) by telomerase. Telomerase RNAs differ greatly in sequence and structure between vertebrates, ciliates and yeasts, but they share a 5'pseudoknot structure close to the template sequence. The vertebrate telomerase RNAs have a 3' H/ACAsnoRNA-like domain.[3][4][5]
Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. This repeat does vary across eukaryotes (see the table on the telomere article for a complete list). The enzyme consists of a protein component (TERT) with reverse transcriptase activity, and an RNA component, encoded by this gene, that serves as a template for the telomere repeat. CCCUAA found near position 50 of the vertebrate TERC sequence acts as the template. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mice suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks.[6]Homologs of TERC can also be found in the Gallid herpes viruses.[7]
↑Lingner, J; Hendrick LL; Cech TR (1994). "Telomerase RNAs of different ciliates have a common secondary structure and a permuted template". Genes Dev. 8 (16): 1984&ndash, 1998. doi:10.1101/gad.8.16.1984. PMID7958872.
↑Fragnet, L; Kut E; Rasschaert D (2005). "Comparative functional study of the viral telomerase RNA based on natural mutations". J Biol Chem. 280 (25): 23502&ndash, 23515. doi:10.1074/jbc.M501163200. PMID15811851.
Marrone A, Dokal I (2007). "Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer". Expert Reviews in Molecular Medicine. 6 (26): 1–23. doi:10.1017/S1462399404008671. PMID15613268.
Yamaguchi H (2007). "Mutations of telomerase complex genes linked to bone marrow failures". Journal of Nippon Medical School = Nihon Ika Daigaku zasshi. 74 (3): 202–9. doi:10.1272/jnms.74.202. PMID17625368.
Soder AI, Hoare SF, Muire S, et al. (1997). "Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting". Genomics. 41 (2): 293–4. doi:10.1006/geno.1997.4621. PMID9143511.
Zhao JQ, Hoare SF, McFarlane R, et al. (1998). "Cloning and characterization of human and mouse telomerase RNA gene promoter sequences". Oncogene. 16 (10): 1345–50. doi:10.1038/sj.onc.1201892. PMID9546436.
Mitchell JR, Wood E, Collins K (1999). "A telomerase component is defective in the human disease dyskeratosis congenita". Nature. 402 (6761): 551–5. doi:10.1038/990141. PMID10591218.
Wong KK, Chang S, Weiler SR, et al. (2000). "Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation". Nat. Genet. 26 (1): 85–8. doi:10.1038/79232. PMID10973255.
Mitchell JR, Collins K (2000). "Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase". Mol. Cell. 6 (2): 361–71. doi:10.1016/S1097-2765(00)00036-8. PMID10983983.
Imoto I, Pimkhaokham A, Fukuda Y, et al. (2001). "SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus". Biochem. Biophys. Res. Commun. 286 (3): 559–65. doi:10.1006/bbrc.2001.5428. PMID11511096.
Vulliamy T, Marrone A, Goldman F, et al. (2001). "The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita". Nature. 413 (6854): 432–5. doi:10.1038/35096585. PMID11574891.
Zhang RG, Zhang RP, Wang XW, Xie H (2004). "Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells". Cell Res. 12 (1): 55–62. doi:10.1038/sj.cr.7290110. PMID11942411.
Yang Y, Chen Y, Zhang C, et al. (2002). "Nucleolar localization of hTERT protein is associated with telomerase function". Exp. Cell Res. 277 (2): 201–9. doi:10.1006/excr.2002.5541. PMID12083802.
Chang JT, Chen YL, Yang HT, et al. (2002). "Differential regulation of telomerase activity by six telomerase subunits". Eur. J. Biochem. 269 (14): 3442–50. doi:10.1046/j.1432-1033.2002.03025.x. PMID12135483.
Sood AK, Coffin J, Jabbari S, et al. (2003). "p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma". Cancer Biol. Ther. 1 (5): 511–7. doi:10.4161/cbt.1.5.167. PMID12496479.